Daré Bioscience prices USD 6 million registered direct offering at USD 1.37 per share

Daré Bioscience priced a registered direct offering of 4,379,581 common shares, or pre-funded warrants, at USD 1.37 per share.

• Gross proceeds are expected to be USD 6 million at closing, before placement agent fees, commissions, and offering expenses.
• The concurrent private placement includes Series A warrants and Series B warrants for up to 4,379,581 shares each; exercisability requires stockholder approval.
• Series A warrants are priced at USD 1.37 and have a five-year term.
• Series B warrants are priced at USD 1.37 and have a two-year term.
• Closing is expected on or about Aug. 17, 2026, subject to customary closing conditions.